Form 8-K - Current report:
SEC Accession No. 0001610618-17-000046
Filing Date
2017-08-09
Accepted
2017-08-09 16:17:24
Documents
3
Period of Report
2017-08-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K cdtx8-kq22017.htm 8-K 28090
2 EARNINGS RELEASE earningsrelease.htm EX-99.1 77772
3 cidara_finala05.jpg GRAPHIC 23896
  Complete submission text file 0001610618-17-000046.txt   140162
Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 858-752-6170
Cidara Therapeutics, Inc. (Filer) CIK: 0001610618 (see all company filings)

EIN.: 461537286 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36912 | Film No.: 171018169
SIC: 2836 Biological Products, (No Diagnostic Substances)